News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
680,097 Results
Type
Article (38836)
Company Profile (249)
Press Release (641012)
Section
Business (203613)
Career Advice (1979)
Deals (35350)
Drug Delivery (79)
Drug Development (80689)
Employer Resources (167)
FDA (16041)
Job Trends (14782)
News (343923)
Policy (32418)
Tag
Academia (2529)
Africa (712)
Alliances (48990)
Alzheimer's disease (1158)
Approvals (15973)
Arizona (176)
Artificial intelligence (80)
Asia (36860)
Australia (5999)
Bankruptcy (351)
Best Places to Work (11339)
Biosimilars (65)
Biotechnology (180)
Breast cancer (69)
C2C Services and Suppliers (78790)
California (2069)
Canada (995)
Cancer (585)
Career advice (1649)
Cell therapy (143)
China (163)
Clinical research (63428)
Collaboration (184)
Colorado (86)
Compensation (100)
Connecticut (88)
COVID-19 (2498)
Cystic fibrosis (78)
Data (468)
Diabetes (94)
Diagnostics (6001)
Drug pricing (71)
Earnings (83691)
Employer resources (142)
Europe (78806)
Events (108028)
Executive appointments (178)
FDA (16331)
Florida (298)
Funding (178)
Gene therapy (99)
GLP-1 (524)
Government (4302)
Healthcare (18617)
Hotbed/Location (480947)
Illinois (269)
Indiana (152)
Infectious disease (2535)
Inflammatory bowel disease (93)
Interviews (306)
IPO (16211)
Job creations (3618)
Job search strategy (1413)
Kansas (94)
Layoffs (397)
Legal (7833)
Lung cancer (120)
Manufacturing (106)
Maryland (425)
Massachusetts (1689)
Medical device (13070)
Medtech (13075)
Mergers & acquisitions (19039)
Metabolic disorders (280)
Michigan (130)
Minnesota (222)
Neuroscience (1337)
New Jersey (640)
New York (649)
NextGen Class of 2024 (6482)
Non-profit (4457)
North Carolina (604)
Northern California (904)
Obesity (170)
Ohio (113)
Opinion (172)
Patents (79)
Pennsylvania (624)
People (55921)
Phase I (19646)
Phase II (27921)
Phase III (20882)
Pipeline (135)
Postmarket research (2549)
Preclinical (8334)
Press Release (64)
Radiopharmaceuticals (230)
Rare diseases (150)
Real estate (5885)
Regulatory (21282)
Research institute (2305)
Resumes & cover letters (347)
South America (1089)
Southern California (839)
Startups (3560)
Texas (270)
United States (9269)
Vaccines (491)
Washington State (261)
Weight loss (137)
Date
Today (186)
Last 7 days (659)
Last 30 days (2740)
Last 365 days (36928)
2024 (27197)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46542)
2018 (35019)
2017 (32111)
2016 (31481)
2015 (37553)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
680,097 Results for "colorcon inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Colorcon, Inc. Launches a New Titanium Dioxide Free Moisture Protection Coating for Pharmaceutical Tablets
Colorcon, a world leader in the development and supply of film coating systems, speciality excipients and functional packaging for the healthcare industries, announces the launch of a new Opadry® film coating system to address the moisture management needs for pharmaceutical tablets, without the use of titanium dioxide.
September 5, 2023
·
1 min read
Deals
Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packaging
Colorcon, Inc. announces that it has completed the acquisition of Airnov Healthcare Packaging, Inc. from Arsenal Capital Partners.
March 2, 2023
·
2 min read
Pharm Country
Colorcon, Inc. Signs Put Agreement with Intent to Acquire Controlled Atmosphere Packaging Specialist Airnov Healthcare Packaging
Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, announces that it has entered into a Put agreement to purchase Airnov Healthcare Packaging, portfolio company of Arsenal Capital Partners, a private equity firm.
January 23, 2023
·
2 min read
Pharm Country
Colorcon Ventures Invests in Novome Biotechnologies, an Engineered Microbial Therapy Company
Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Novome Biotechnologies, a clinical-stage company that develops engineered oral microbial therapies.
September 15, 2022
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
i2O Therapeutics Receives Strategic Investment from Colorcon Ventures and Enters into Research Collaboration with Colorcon
i2O Therapeutics, an innovative biotech company developing a platform to enable oral delivery of traditionally injectable biological drugs, has received a strategic investment from Colorcon Ventures, the corporate venture fund of Colorcon Inc.
December 3, 2020
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”).
June 28, 2024
·
4 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
1 of 68,010
Next